Live from the NIH registry
Studies recruiting near Ocala right now
Top 25 of 137 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
Ocala Oncology Florida Cancer Affiliates - Main /ID# 234228 — Ocala, Florida (0.9 mi)
· Sponsor: AbbVie
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Non-small Cell Lung Cancer, Melanoma
Phase 1
Interventional 174 participants sought
Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (22.6 mi)
· Sponsor: Boehringer Ingelheim
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: SCRI Development Innovations, LLC
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US029 — Ocala, Florida (0.9 mi)
· Sponsor: Incyte Corporation
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Phase 2
Interventional 200 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: 89bio, Inc.
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (22.7 mi)
· Sponsor: Eli Lilly and Company
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Ocala, Florida (0.9 mi)
· Sponsor: American Society of Clinical Oncology
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease
Phase 2
Interventional 240 participants sought
Nature Coast Clinical Research - Inverness — Inverness, Florida (26.0 mi)
· Sponsor: Calico Life Sciences LLC
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
Healthy Participants, Dyslipidemia
Phase 1
Interventional 136 participants sought
Research Site — Inverness, Florida (26.0 mi)
· Sponsor: AstraZeneca
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer's Disease
Phase 2
Interventional 407 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Tizona Therapeutics, Inc
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 734 participants sought
Florida Cancer Affiliates - Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: NovoCure GmbH
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Phase 3
Interventional 1,800 participants sought
Altimmune Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Altimmune, Inc.
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Phase 3
Interventional 426 participants sought
Local Institution - 1608 — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: DalCor Pharmaceuticals
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Ocala GI Research — Ocala, Florida (0.9 mi)
· Sponsor: Eccogene
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Cognitive Dysfunction, Lewy Body Disease
Phase 2
Interventional 350 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company